πŸ‡ΊπŸ‡Έ FDA
Patent

US 10029988

HDAC inhibitors

granted A61PA61P21/00A61P21/02

Quick answer

US patent 10029988 (HDAC inhibitors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P21/00, A61P21/02, A61P21/04, A61P25/00